These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 10725117)
1. Characterization of the major DNA adduct formed by alpha-hydroxy-N-desmethyltamoxifen in vitro and in vivo. Gamboa da Costa G; Hamilton LP; Beland FA; Marques MM Chem Res Toxicol; 2000 Mar; 13(3):200-7. PubMed ID: 10725117 [TBL] [Abstract][Full Text] [Related]
2. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry. Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and investigation of alpha-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen. Gamboa da Costa G; Marques MM; Freeman JP; Beland FA Chem Res Toxicol; 2003 Sep; 16(9):1090-8. PubMed ID: 12971796 [TBL] [Abstract][Full Text] [Related]
4. Further characterization of the DNA adducts formed in rat liver after the administration of tamoxifen, N-desmethyltamoxifen or N, N-didesmethyltamoxifen. Brown K; Heydon RT; Jukes R; White IN; Martin EA Carcinogenesis; 1999 Oct; 20(10):2011-6. PubMed ID: 10506118 [TBL] [Abstract][Full Text] [Related]
5. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives. Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763 [TBL] [Abstract][Full Text] [Related]
6. Identification of the major tamoxifen-DNA adducts in rat liver by mass spectroscopy. Rajaniemi H; Rasanen I; Koivisto P; Peltonen K; Hemminki K Carcinogenesis; 1999 Feb; 20(2):305-9. PubMed ID: 10069469 [TBL] [Abstract][Full Text] [Related]
7. Identification of tamoxifen-DNA adducts induced by alpha-acetoxy-N-desmethyltamoxifen. Kitagawa M; Ravindernath A; Suzuki N; Rieger R; Terashima I; Umemoto A; Shibutani S Chem Res Toxicol; 2000 Aug; 13(8):761-9. PubMed ID: 10956064 [TBL] [Abstract][Full Text] [Related]
8. Stereoselective metabolic activation of alpha-hydroxy-N-desmethyltamoxifen: the R-isomer forms more DNA adducts in rat liver cells. Osborne MR; Hewer A; Phillips DH Chem Res Toxicol; 2004 May; 17(5):697-701. PubMed ID: 15144227 [TBL] [Abstract][Full Text] [Related]
9. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene. Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033 [TBL] [Abstract][Full Text] [Related]
10. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans. Beland FA; Churchwell MI; Doerge DR; Parkin DR; Malejka-Giganti D; Hewer A; Phillips DH; Carmichael PL; Gamboa da Costa G; Marques MM J Natl Cancer Inst; 2004 Jul; 96(14):1099-104. PubMed ID: 15265972 [TBL] [Abstract][Full Text] [Related]
11. Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen. Osborne MR; Hewer A; Hardcastle IR; Carmichael PL; Phillips DH Cancer Res; 1996 Jan; 56(1):66-71. PubMed ID: 8548777 [TBL] [Abstract][Full Text] [Related]
12. Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods. Schild LJ; Phillips DH; Osborne MR; Hewer A; Beland FA; Churchwell MI; Brown K; Gaskell M; Wright E; Poirier MC Mutagenesis; 2005 Mar; 20(2):115-24. PubMed ID: 15755801 [TBL] [Abstract][Full Text] [Related]
13. Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen. Gamboa da Costa G; Marques MM; Fu X; Churchwell MI; Wang YP; Doerge DR; Beland FA Cancer Lett; 2007 Nov; 257(2):191-8. PubMed ID: 17765393 [TBL] [Abstract][Full Text] [Related]
14. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days. Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo. Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775 [TBL] [Abstract][Full Text] [Related]
16. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen. Pathak DN; Pongracz K; Bodell WJ Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794 [TBL] [Abstract][Full Text] [Related]
17. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment. Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo. Beland FA; McDaniel LP; Marques MM Carcinogenesis; 1999 Mar; 20(3):471-7. PubMed ID: 10190564 [TBL] [Abstract][Full Text] [Related]
19. Identification of tamoxifen-DNA adducts formed by 4-hydroxytamoxifen quinone methide. Marques MM; Beland FA Carcinogenesis; 1997 Oct; 18(10):1949-54. PubMed ID: 9364005 [TBL] [Abstract][Full Text] [Related]
20. DNA adduct formation by tamoxifen and structurally-related compounds in rat liver. Rajaniemi H; Mäntylä E; Hemminki K Chem Biol Interact; 1998 May; 113(2):145-59. PubMed ID: 9717515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]